138 related articles for article (PubMed ID: 1877444)
1. U74006F, a novel 21-aminosteroid, inhibits in vivo lipid peroxidation but fails to limit infarct size in a canine model of myocardial ischemia reperfusion.
Ovize M; de Lorgeril M; Ovize A; Ciavatti M; Delaye J; Renaud S
Am Heart J; 1991 Sep; 122(3 Pt 1):681-9. PubMed ID: 1877444
[TBL] [Abstract][Full Text] [Related]
2. Effects of U74006F, a novel inhibitor of lipid peroxidation, in stunned reperfused canine myocardium.
Holzgrefe HH; Buchanan LV; Gibson JK
J Cardiovasc Pharmacol; 1990 Feb; 15(2):239-48. PubMed ID: 1689419
[TBL] [Abstract][Full Text] [Related]
3. Does preconditioning protect the coronary vasculature from subsequent ischemia/reperfusion injury?
Bauer B; Simkhovich BZ; Kloner RA; Przyklenk K
Circulation; 1993 Aug; 88(2):659-72. PubMed ID: 8339428
[TBL] [Abstract][Full Text] [Related]
4. The lazaroid U74006F, a 21-aminosteroid inhibitor of lipid peroxidation, attenuates myocardial injury from ischemia and reperfusion.
Carrea FP; Lesnefsky EJ; Kaiser DG; Horwitz LD
J Cardiovasc Pharmacol; 1992 Aug; 20(2):230-5. PubMed ID: 1381014
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment with U74006F improves neurologic outcome following complete cerebral ischemia in dogs.
Perkins WJ; Milde LN; Milde JH; Michenfelder JD
Stroke; 1991 Jul; 22(7):902-9. PubMed ID: 1853410
[TBL] [Abstract][Full Text] [Related]
6. Effect of 21-aminosteroid lipid peroxidation inhibitor, U74006F, in the rat middle cerebral artery occlusion model.
Umemura K; Wada K; Uematsu T; Mizuno A; Nakashima M
Eur J Pharmacol; 1994 Jan; 251(1):69-74. PubMed ID: 8137871
[TBL] [Abstract][Full Text] [Related]
7. Effect of the aminosteroid U74006F after cardiopulmonary arrest in dogs.
Natale JE; Schott RJ; Hall ED; Braughler JM; D'Alecy LG
Stroke; 1988 Nov; 19(11):1371-8. PubMed ID: 3188122
[TBL] [Abstract][Full Text] [Related]
8. Reduction of infarct size during myocardial ischemia and reperfusion by lazaroid U-74500A, a nonglucocorticoid 21-aminosteroid.
Levitt MA; Sievers RE; Wolfe CL
J Cardiovasc Pharmacol; 1994 Jan; 23(1):136-40. PubMed ID: 7511726
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of renal reperfusion injury in rats by the 21-aminosteroid U74006F.
Stanley JJ; Goldblum JR; Frank TS; Zelenock GB; D'Alecy LG
J Vasc Surg; 1993 Apr; 17(4):685-9. PubMed ID: 8464086
[TBL] [Abstract][Full Text] [Related]
10. 21-Aminosteroid lipid peroxidation inhibitor U74006F protects against cerebral ischemia in gerbils.
Hall ED; Pazara KE; Braughler JM
Stroke; 1988 Aug; 19(8):997-1002. PubMed ID: 3400111
[TBL] [Abstract][Full Text] [Related]
11. Prevention of lipid peroxidation does not prevent oxidant-induced myocardial contractile dysfunction.
Kong Y; Lesnefsky EJ; Ye J; Horwitz LD
Am J Physiol; 1994 Dec; 267(6 Pt 2):H2371-7. PubMed ID: 7810737
[TBL] [Abstract][Full Text] [Related]
12. Improved donor myocardial recovery with a new lazaroid lipid antiperoxidant in the isolated canine heart.
Hendry PJ; Anstadt MP; Plunkett MD; Amato MT; Menius JA; Lowe JE
J Heart Lung Transplant; 1992; 11(4 Pt 1):636-45. PubMed ID: 1498126
[TBL] [Abstract][Full Text] [Related]
13. The 21-aminosteroid U74006F reduces systemic lipid peroxidation, improves neurologic function, and reduces mortality after cardiopulmonary arrest in dogs.
Natale JE; Schott RJ; Hall ED; Braughler JM; D'Alecy LG
Prog Clin Biol Res; 1989; 308():891-6. PubMed ID: 2780736
[No Abstract] [Full Text] [Related]
14. The effect of the 21-aminosteroid U74006F in a rabbit model of thromboembolic stroke.
Wilson JT; Bednar MM; McAuliffe TL; Raymond S; Gross CE
Neurosurgery; 1992 Nov; 31(5):929-33; discussion 933-4. PubMed ID: 1436419
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion.
Forman MB; Pitarys CJ; Vildibill HD; Lambert TL; Ingram DA; Virmani R; Murray JJ
J Am Coll Cardiol; 1992 Jan; 19(1):205-16. PubMed ID: 1729335
[TBL] [Abstract][Full Text] [Related]
16. Prevention of reperfusion injury in surgically induced gastric dilatation-volvulus in dogs.
Badylak SF; Lantz GC; Jeffries M
Am J Vet Res; 1990 Feb; 51(2):294-9. PubMed ID: 2301843
[TBL] [Abstract][Full Text] [Related]
17. Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function.
Schaer GL; Hursey TL; Abrahams SL; Buddemeier K; Ennis B; Rodriguez ER; Hubbell JP; Moy J; Parrillo JE
Circulation; 1994 Dec; 90(6):2964-75. PubMed ID: 7994844
[TBL] [Abstract][Full Text] [Related]
18. Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia/reperfusion injury in canine heart.
Tamura Y; Chi LG; Driscoll EM; Hoff PT; Freeman BA; Gallagher KP; Lucchesi BR
Circ Res; 1988 Nov; 63(5):944-59. PubMed ID: 3180357
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of the lazaroid U74006F in cold ischemia-reperfusion injury of the liver.
Cosenza CA; Cramer DV; Cunneen SA; Tuso PJ; Wang HK; Makowka L
Hepatology; 1994 Feb; 19(2):418-25. PubMed ID: 8294099
[TBL] [Abstract][Full Text] [Related]
20. Effects of new 21-aminosteroid tirilazad mesylate (U74006F) on chronic cerebral vasospasm in a "two-hemorrhage" model of beagle dogs.
Matsui T; Asano T
Neurosurgery; 1994 Jun; 34(6):1035-9; discussion 1039. PubMed ID: 8084388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
